XTMAB-16

· Xentria, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XTMAB-16, covering 2025-01-14 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis [Phase 1, Phase 2]